Investing.com -- Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to initiate a clinical study aimed at optimizing muscle mass during ...
El 39% de la población gallega tiene sobrepeso y el 16,5% tiene obesidad, según refleja un estudio difundido por la Xunta ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), known for its efforts in combating obesity and maintaining impressive gross profit margins of 73%, disclosed today its plan to conduct a ...
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today ...
NATICK, Mass., January 23, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to ...
El estudio explorará la combinación del Programa Allurion, que incluye el Balón Allurion y Virtual Care Suite, con agonistas del GLP-1 para mejorar potencialmente la retención de masa muscular y la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback